Cannabidiol News and Research

Latest Cannabidiol News and Research

Studies show hemp's potential for treating ovarian cancer

Results from some of the first studies to examine hemp's ability to fight cancer show that it might one day be useful as plant-based treatment for ovarian cancer. Hemp is part of the same cannabis family as marijuana but doesn't have any psychoactive properties or cause addiction.

24 Apr 2018

Study provides guidance on using cannabis for treatment of stress, anxiety, and depression

In a first-of-a-kind study, Washington State University scientists examined how peoples' self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home.

20 Apr 2018

FDA approves marijuana based medication for epilepsy treatment

An advisory panel from the United States Food and Drug Administration (FDA) has recommended the approval of a novel epilepsy drug that is made up of ingredients from marijuana. The agency normally follows the recommendations of the advisory panels regarding approvals and rejections of applications of new drugs. The recommendation statement came yesterday (19th April 2018).

19 Apr 2018

Non-psychoactive cannabis ingredient could reduce risk of relapse among recovering addicts

A preclinical study in rats has shown that there might be value in using a non-psychoactive and non-addictive ingredient of the Cannabis sativa plant to reduce the risk of relapse among recovering drug and alcohol addicts.

23 Mar 2018

Cannabis use triggers schizophrenia and other psychiatric issues

Schizophrenia and other psychiatric issues may be triggered by marijuana use, according to a research analysis in the Journal of the American Osteopathic Association.

12 Feb 2018

Major labeling inaccuracies in cannabidiol extract products

There is a growing demand among consumers for marijuana containing products supposedly providing several health benefits in a range od diseases and conditions. This has spawned thousands of websites that are selling these products online. Many of these contain mislabeled cannabidiol (CBD) or a compound found in cannabis or marijuana finds a new study.

7 Nov 2017

Study finds mislabeling in nearly 70% of cannabidiol products sold online

In recent years, there has been an increased interest in the medicinal use of Cannabidiol (CBD), a chemical that naturally occurs the in cannabis plant (aka "marijuana"). There is interest in CBD as a medicine because there is some evidence that it has medical benefits,

7 Nov 2017

Mislabeling of cannabidiol products poses safety and efficacy issues for consumers

Growing consumer demand for cannabis-related products purported to have medicinal benefits has created an environment where people are using mislabeled cannabidiol products sold online.

7 Nov 2017

FDA issues warning letters to companies illegally selling products that claim to cure cancer

As part of the U.S. Food and Drug Administration's ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes.

2 Nov 2017

FDA warning on miracle marijuana cures for cancer

Yesterday, 1st November 2017, the U.S. Food and Drug Administration, FDA, released a statement warning the general public against fraudulent claims regarding marijuana based cancer cures. The FDA has also issued warnings in writing to four companies that are selling such products online illegally. These products are being advertised as miracle cures for cancers and several serious conditions.

2 Nov 2017

Systematic review finds lack of data on medical cannabis use in children and adolescents

A systematic review of published studies on the use of medical cannabis in children and adolescents finds a notable lack of studies and a minimal number of the randomized, controlled trials needed to confirm the effectiveness of a treatment.

23 Oct 2017

Cannabidiol appears to protect against long-term negative psychiatric effects of THC

A study reported Sept. 5 by neuroscientists at Indiana University finds that a non-psychoactive compound in cannabis called cannabidiol, or CBD, appears to protect against the long-term negative psychiatric effects of THC, the primary psychoactive ingredient in cannabis.

6 Sep 2017

Researchers receive $3.8 million NIH grant to study medical marijuana's impact on opioid use for pain

The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System a five-year, $3.8 million grant for the first long-term study to test whether medical marijuana reduces opioid use among adults with chronic pain, including those with HIV.

8 Aug 2017

Compound derived from cannabis may alter blood levels of antiepileptic drugs

New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used antiepileptic drugs.

7 Aug 2017

Cannabinoids found to be suitable treatment for migraine attacks

A study presented at the Congress of the European Academy of Neurology in Amsterdam confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.

24 Jun 2017

Cannabidiol shows promise to reduce seizures for people with difficult-to-treat epilepsy

Taking cannabidiol may cut seizures in half for some children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy, according to new information released today from a large scale controlled clinical study that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston, April 22 to 28, 2017.

19 Apr 2017

Cannabidiol News and Research

Latest Cannabidiol News and Research

Studies show hemp's potential for treating ovarian cancer

Study provides guidance on using cannabis for treatment of stress, anxiety, and depression

FDA approves marijuana based medication for epilepsy treatment

Non-psychoactive cannabis ingredient could reduce risk of relapse among recovering addicts

Cannabis use triggers schizophrenia and other psychiatric issues

Major labeling inaccuracies in cannabidiol extract products

Study finds mislabeling in nearly 70% of cannabidiol products sold online

Mislabeling of cannabidiol products poses safety and efficacy issues for consumers

FDA issues warning letters to companies illegally selling products that claim to cure cancer

FDA warning on miracle marijuana cures for cancer

Systematic review finds lack of data on medical cannabis use in children and adolescents

Cannabidiol appears to protect against long-term negative psychiatric effects of THC

Researchers receive $3.8 million NIH grant to study medical marijuana's impact on opioid use for pain

Compound derived from cannabis may alter blood levels of antiepileptic drugs

Cannabinoids found to be suitable treatment for migraine attacks

Cannabidiol shows promise to reduce seizures for people with difficult-to-treat epilepsy

Component of cannabis may help alleviate anxiety-related and substance abuse disorders

Experts highlight urgent need to explore how cannabis use can be made safer

Researchers develop new method to detect cannabinoids in breast milk

Study detects biomarkers from secondhand marijuana smoke exposure in children

Pittcon Highlights: Cannabis & Psychedelics eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cannabidiol News and Research

Latest Cannabidiol News and Research

Pittcon Highlights: Cannabis & Psychedelics eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in